Skip to main content
Quest Diagnostics

Comprehensive Outcomes for After Cancer Health: COACH

American Society of Clinical Oncology

ASCO 2023

Chicago, IL, June 2-6 , 2023

Poster presentation: Comprehensive Outcomes for After Cancer Health: COACH

Authors: Lally RM, Schmidt R, Tlusty G, Jackson MK, Arthur E, Barr A, Flora L, Hammer MJ, Jessica Jones T,  Kelly DL, Krok-Schoen JL, Loftis J, Saligan L, Starkweather A,  Vazquez M, Whisenant M, Wright AA, Brassil KJ

Specialty: Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by Pack Health, a subsidiary of Quest Diagnostics.

Related content

Audio Podcast
Optimize Oncology Care with Clinical Pathways
On-Demand Webinar
Innovations within Precision Oncology Evolution of a Biomarker a Case Study of KRAS-G12C
On-Demand Webinar
KRAS G12C Mutation: An Emerging Biomarker for NSCLC
On-Demand Webinar
Hereditary Cancer Care Starts in Primary Care

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.